Related Experiment Video
Updated: Jan 16, 2026
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Immune Cells Mediate the Causal Pathway Linking Multisite Chronic Pain to Asthma: A Mediation Mendelian Randomization
Jie-Hai Chen1, Nian-Hua Deng2, Yong-Cheng Li1
1Department of Anesthesiology, Dongguan Maternal and Child Health Care Hospital, Dongguan, Guangdong Province, 523125, People's Republic of China.
Background:
Cumulative evidence from observational studies has revealed associations between chronic pain (CP) and asthma. However, it remains unclear whether these associations indicate a causal relationship. In this study, we aimed to assess the causal relationships between CP and asthma.
Methods:
First, linkage disequilibrium score regression (LDSC) analysis was used to estimate the genetic correlations between 9 types of CP (including multisite chronic pain, knee, back, neck/shoulder, headaches, hip, stomach/abdominal, facial, and general CP) and asthma. Conventional Mendelian randomization (MR) approaches and a new MR method, Causal Analysis Using Summary Effect estimates (CAUSE), were performed to test bidirectional causal relationships between genetically predicted CP and asthma. Finally, mediation analysis was conducted to establish whether immune cells and inflammatory cytokines causally mediate any associations.
Results:
For the LDSC analysis, several significant genetic correlations (rg) were observed, such as multisite chronic pain (MCP) and asthma (rg = 0.442, P = 7.23×10-52). For the MR analysis, we identified that genetically determined MCP (odds ratio [OR] 2.34, 95% confidence interval [CI] 1.84-2.97, P = 3.51×10-12) was significantly associated with a higher risk of asthma. For the mediation analysis, the three immune-cell phenotypes (including CD3 on activated CD4 regulatory T cells, CD3 on activated and secreting CD4 regulatory T cells, and CD3 on CD39+ CD4+ T cells) were each found to mediate 4.6-5.0% of the total effect linking MCP to asthma, underscoring their partial mediating role in this causal pathway. Unexpectedly, other types of pain showed no correlation with asthma risk.
Conclusion:
Our findings revealed that MCP is significantly associated with a higher risk of asthma, which is partially mediated by immune cells.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:29Asthma-I: Introduction
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...